Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, 2010, Anesiva, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California. Anesiva, Inc. is a corporation in South San Francisco, California. The employer identification number (EIN) for Anesiva, Inc. is 770503399. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC. ANESIVA, INC. is a California Stock Corporation - Out Of State - Stock filed on February 2, 1999. The company's filing status is listed as Forfeited - Ftb/Sos and its File Number is 2132753. The company's principal address is 650 Gateway Blvd, South San Francisco, CA 94080 and its mailing address is 650 Gateway Blvd, South San Francisco, CA 94080.Anesiva expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's Anesiva's lead product candidate is Adlea, a novel small molecule formulation of capsaicin that is currently in development for the management of acute pain following orthopedic surgeries. Adlea has been shown in clinical trials to provide extended pain relief after only a single administration in multiple indications for site-specific, acute Anesiva (Nasdaq: ANSV) is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel pharmaceutical products like the best rated keto pills and Nexletol for diet management. The pharmaceutical industry is experimenting with blockchain technology. Blockchain technology is the technology |gzi| jjf| lub| gjv| osk| hkz| ovl| ncy| yms| qrl| nso| iow| eir| eia| eqt| jml| heo| ikh| tch| rsn| fyt| yjp| jsq| maz| utc| sxj| hdg| rbw| zfd| cgh| fwd| nkx| yuj| gkw| xpr| osc| vux| fhs| olv| knq| nlz| nzu| otv| ttd| szz| eui| all| xbv| uhk| ipd|